The science
The evidence that matters for this cream is the retinaldehyde evidence, and it is older and better than most over-the-counter retinoid claims. Retinaldehyde sits one enzymatic oxidation from retinoic acid in the skin's own conversion pathway, and its clinical case was built in a series of French trials in the late 1990s. A 1998 study in the Journal of the American Academy of Dermatology used profilometry to measure photodamage after treatment with 0.05 percent retinaldehyde or 0.05 percent retinoic acid and found both produced significant reductions in wrinkle depth and surface roughness, with the two retinoids performing comparably, which is why 0.05 percent became the reference retinaldehyde strength and why this tube's declared percentage is meaningful. A 1999 study in Dermatology then compared the tolerance of retinol, retinaldehyde and retinoic acid under maximised and long-term conditions and placed retinaldehyde between the two, clearly better tolerated than retinoic acid and close to retinol, which is the trade this cream offers: near-prescription efficacy at a cosmetic-grade irritation profile. Retinaldehyde is unstable in water and light, and the phosphatidylcholine, sucrose distearate and biosaccharide gum around it on this list are the signature of a liposomal or encapsulated system that protects the molecule and slows its release, though VT publishes no stability or release data. Niacinamide at sixth is the second well-supported ingredient; at the two to five percent levels used in leave-on trials it reduces transepidermal water loss, increases barrier lipid production and lowers pigment transfer, all of which make it a rational partner for a retinoid in the same cream, and the mild flushing some people get from niacinamide adds to rather than subtracts from the retinal's early redness. The ceramide, cholesterol and phytosphingosine set has good evidence for barrier repair at working concentrations in moisturisers and is here at trace positions, so its contribution is real but small. The rest of the list, ginseng, glutathione, thioctic acid, caffeine, sodium DNA and nine peptides, carries no evidence for brightening, firming or regeneration at the levels these positions imply; topical glutathione has one small placebo-controlled trial in its oxidised form at two percent, PDRN's data are for injected forms, and the peptides have never been tested in a retinoid cream. Nothing about this specific formulation has been trialled, so the assessment rests on the retinaldehyde literature applied to a cream that carries the right dose in a plausible delivery form.
References 3 ShowHide
- Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment — Journal of the American Academy of Dermatology (1998)
- Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions — Dermatology (1999)
- Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women — Clinical, Cosmetic and Investigational Dermatology (2014)